Drawing for HANX

USPTO serial 79289661

HANX

Reviewed by CopyMark Law Group

Reg. 6430513Status 700Renewal
Filing date
Status date
Registration date
Jul 27, 2021
Examiner
STEIN, JAMES W
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with HANX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,046*

Plus Government fees of $1,300

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Shoko Naruo

Shoko Naruo Thompson Coburn LLPOne US Bank PlazaSt. Louis, MO 63101UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Contraceptive preparations and substances, namely, chemical contraceptives, contraceptive sponges, contraceptive foams, oral contraceptives, injectable contraceptives; contraceptive preparations; personal lubricants; sexual stimulant liquids, creams and gels; sanitary preparations and articles, namely, chemical contraceptives; feminine hygiene products, namely, chemical contraceptives, tampons, tampon applicators, sanitary pads, sanitary napkins, feminine hygiene pads, panty liners, adult incontinence pads, and pre-moistened medicated towelettes; vitamins and vitamin preparations; dietary supplements; pharmaceutical and medical preparations, namely, chemical contraceptives, vaginal, oral and topical antifungal preparations, vaginal, oral and topical preparations for the prevention and treatment of infections, thrush, bacterial vaginosis, cystitis, and sexually transmitted infections; pharmaceutical and medical preparations for the treatment of hormonal disorders and imbalances; pharmaceutical and medical preparations, namely, birth control pills and contraceptive pills; chemical preparations for medical and pharmaceutical purposes, namely, chemical contraceptives, vaginal, oral and topical antifungal preparations, vaginal, oral and topical preparations for the prevention and treatment of infections, thrush, bacterial vaginosis, cystitis, and sexually transmitted infections; chemical preparations for medical and pharmaceutical purposes for the treatment of hormonal disorders and imbalances; chemical preparations for medical and pharmaceutical purposes, namely, birth control pills and contraceptive pills; natural remedies, namely, vaginal, oral and topical antifungal preparations, vaginal, oral and topical preparations for the prevention and treatment of infections, thrush, bacterial vaginosis, cystitis, and sexually transmitted infections; natural remedies for the treatment of hormonal disorders and imbalances; natural remedies, namely, birth control pills and contraceptive pills; pregnancy testing preparations; ovulation test kits; fertility testing preparations in the nature of urine and blood test kits for home and clinical use; fertility test kits for home and clinical use in the nature of urine and blood test kits for home and clinical use; diagnostic test kits for use in detecting sexually transmitted diseases and infections in the nature of drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; parts and fittings for ovulation test kits, thrush treatment kits, bacterial vaginosis treatment kits, cystitis treatment kits, fertility test kits in the nature of urine and blood test kits for home use and clinical use, and diagnostic test kits for testing sexually transmitted diseases and infections in the nature of drug testing kits comprised of medical diagnostic reagents and assays for testing body fluidsACTIVE—
010Condoms for medical purposes; condoms; sex toys; contraceptive appliances, namely, contraceptive apparatus and condoms; contraceptive devices, namely, condoms; contrivances made from natural rubber for contraceptive purposes, namely, condoms; sexual aids, namely, condoms and sex toys; parts and fittings for contraceptive apparatus and sex toysACTIVE—
035Retail and online retail services in the nature of retail store services, all featuring contraceptive preparations and substances, personal lubricants, sexual stimulant liquids, creams and gels, sanitary preparations and articles, feminine hygiene products, vitamins and vitamin preparations, dietary supplements, pharmaceutical and medical preparations, chemical preparations for medical and pharmaceutical purposes, natural remedies, and parts and fittings for ovulation test kits, thrush treatment kits, bacterial vaginosis treatment kits, cystitis treatment kits, fertility test kits, and diagnostic test kits for testing sexually transmitted diseases and infections; retail and online retail services in the nature of retail store services, all featuring pregnancy testing preparations, ovulation test kits, fertility test kits, kits for testing for sexually transmitted diseases and infections, condoms for medical purposes, condoms, sex toys, contraceptive appliances, contraceptive devices, contrivances made from natural rubber for contraceptive purposes, sexual aids, and parts and fittings for contraceptive apparatus and sex toys; mail order services, and wholesale services in the nature of wholesale distributorships, all featuring contraceptive preparations and substances, personal lubricants, sexual stimulant liquids, creams and gels, sanitary preparations and articles, feminine hygiene products, vitamins and vitamin preparations, dietary supplements, pharmaceutical and medical preparations, chemical preparations for medical and pharmaceutical purposes, natural remedies, and parts and fittings for ovulation test kits, thrush treatment kits, bacterial vaginosis treatment kits, cystitis treatment kits, fertility test kits, and diagnostic test kits for testing sexually transmitted diseases and infections; mail order services, and wholesale services in the nature of wholesale distributorships, all featuring pregnancy testing preparations, ovulation test kits, fertility test kits, kits for testing for sexually transmitted diseases and infections, condoms for medical purposes, condoms, sex toys, contraceptive appliances, contraceptive devices, contrivances made from natural rubber for contraceptive purposes, sexual aids, and parts and fittings for contraceptive apparatus and sex toysACTIVE—
044Medical services; medical and healthcare clinics in the nature of medical clinics; medical testing of blood; pregnancy testing services; fertility testing and treatment services, namely, human fertility treatment services; medical testing for sexually transmitted diseases and infections for diagnostic and treatment purposes; information, advisory and consultancy services relating to human fertility treatment, reproductive health, sexual health, women's health and intimate healthACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 27, 2026REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jun 11, 2026CHLDCHANGE OF OWNER RECEIVED FROM IB—
Jan 10, 2022FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Dec 22, 2021FICSFINAL DISPOSITION NOTICE SENT TO IB—
Dec 22, 2021FIMPFINAL DISPOSITION PROCESSED—
Nov 13, 2021NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 27, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 27, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 11, 2021GPNXNOTIFICATION PROCESSED BY IB—
May 11, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 11, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 21, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 21, 2021OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Apr 21, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 7, 2021PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 31, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 31, 2021XAECEXAMINER'S AMENDMENT ENTERED—
Mar 31, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 31, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 31, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 31, 2021ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Mar 31, 2021PBERWITHDRAWN FROM PUB - EXAMINING ATTORNEY REQUEST—
Mar 26, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 26, 2021XAECEXAMINER'S AMENDMENT ENTERED—
Mar 26, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 26, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 26, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 26, 2021ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Feb 23, 2021PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Feb 5, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 5, 2021XAECEXAMINER'S AMENDMENT ENTERED—
Feb 5, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 5, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 5, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 4, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 4, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 2, 2021ALIEASSIGNED TO LIE—
Oct 26, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 28, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Sep 28, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 28, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 28, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 28, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Sep 27, 2020RFNTREFUSAL PROCESSED BY IB—
Sep 6, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Sep 2, 2020RFRRREFUSAL PROCESSED BY MPU—
Jul 30, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jul 29, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 28, 2020DOCKASSIGNED TO EXAMINER—
Jul 25, 2020MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 21, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 16, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance